Related references
Note: Only part of the references are listed.PET imaging of tumor angiogenesis in mice with VEGF-A-targeted 86Y-CHX-A-DTPA-bevacizumab
Tapan K. Nayak et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients
Pier Luigi Zinzani et al.
CLINICAL CANCER RESEARCH (2010)
A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical Parameters
Anna K. Nowak et al.
CLINICAL CANCER RESEARCH (2010)
PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-AaEuro3-DTPA-cetuximab
Tapan K. Nayak et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Preparation, Biological Evaluation, and Pharmacokinetics of the Human Anti-HER1 Monoclonal Antibody Panitumumab Labeled with 86Y for Quantitative PET of Carcinoma
Tapan K. Nayak et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma
Rabab Gaafar et al.
LUNG CANCER (2010)
Malignant Pleural Mesothelioma
Anne S. Tsao et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Asbestos-induced lung diseases: an update
David W. Kamp
TRANSLATIONAL RESEARCH (2009)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
Haining Yang et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2008)
Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma
K. Okuda et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view
C. Andrew Boswell et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group study
Linda L. Garland et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Update on the molecular biology of malignant mesothelioma
Amie Y. Lee et al.
CANCER (2007)
Potentiation of high-LET radiation by gemcitabine: Targeting HER2 with trastuzumab to treat disseminated peritoneal disease
Diane E. Milenic et al.
CLINICAL CANCER RESEARCH (2007)
EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma
J. G. Edwards et al.
LUNG CANCER (2006)
A phase I trial of 90Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies
Jeffrey Y. C. Wong et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2006)
EGFR overexpression in malignant pleural mesothelioma - An immunohistochemical and molecular study with clinico-pathological correlations
A Destro et al.
LUNG CANCER (2006)
Use of imaging in the management of malignant pleural mesothelioma
RE Benamore et al.
CLINICAL RADIOLOGY (2005)
Medical progress - Advances in malignant mesothelioma
BWS Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
New agents in the management of advanced mesothelioma
NJ Vogelzang et al.
SEMINARS IN ONCOLOGY (2005)
Gefitinib in patients with malignant mesothelioma: A phase II study by the cancer and leukemia group B
R Govindan et al.
CLINICAL CANCER RESEARCH (2005)
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours
A Helisch et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Targeting of HER2 antigen for the treatment of disseminated peritoneal disease
DE Milenic et al.
CLINICAL CANCER RESEARCH (2004)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin™
K Garmestani et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies
CM Richman et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres
SP Faux et al.
CARCINOGENESIS (2000)
Share Paper
